Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 5 Sarcoma 4 Neoplasms 4 Hematologic Neoplasms 4 Breast Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Melanoma 3 Glioma 3 Thyroid Cancer, Papillary 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Lymphoproliferative Disorders 2 Leukemia, Myeloid, Acute 2 Central Nervous System Neoplasms 2 Wilms Tumor 1 Uveal Melanoma 1 Thrombocytosis 1 Solid Tumors 1 Solid Tumor 1 Sarcoma, Ewing 1 Recurrence 1 Rare Tumour 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Noonan Syndrome 6 1

Interventions

entrectinib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Solid Tumors × entrectinib × Clear all

NCT02097810 2021-06-09

STARTRK-1

Hoffmann-La Roche

Phase 1 Completed

84 enrolled 1 FDA

Other solid neoplasm

Locally Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡